Short Stocks

MannKind Corporation: Dilution Is in the Cards

As MannKind spends precious cash, it moves closer to the next capital raise (a.k.

Bear’s Eyes Are on Teva Pharmaceutical Industries Ltd (ADR) Earnings Due Next Week

RBC Capital’s Randall Stanicky says everything rides on Teva’s power to keep a grip on 2020 revenue.

Bearish Valeant Pharmaceuticals Intl Inc (VRX) Analyst Sent Shares Tumbling

Goldman Sachs’ Dana Flanders sheds new insights on Valeant from a bearish standpoint, spotting 5% in loss potential for the stock.

Should You Trade or Invest in Teva Pharmaceutical Industries Ltd (ADR)? Thoughts from a Bear

RBC Capital’s Randall Stanicky wonders how strong is Teva’s long-term value investor support to be able to “absorb” a guidance misstep?

General Electric Company (GE): Questions Still Circle FCF Levels, Says Oppenheimer

Oppenheimer’s Christopher Glynn says while some GE questions have been met with answers, FCF questions hover around valuation.

What Does General Electric Company (GE) Insurance Portfolio Review Spell Out for Potential Breakup?

Oppenheimer’s Christopher Glynn notes that the review lends more weight to the idea of a breakup of GE’s businesses.

General Electric Company (GE) Has a Bear Tempted to Upgrade, But Not Quite Yet

Oppenheimer’s Christopher Glynn says it is premature to make the “pivot” from bearish to the sidelines on GE stock.

Uh Oh, Roku Inc Has a New Bear in Town

Morgan Stanley’s Benjamin Swinburne questions Roku’s monetization opportunity in a world where market share on consumer time spent keeps rising towards channels (Netflix, Youtube) that fail to realize big sales.

Tesla Inc (TSLA): This Bear Reduces Model 3 Production Expectations By 75%

Cowen’s Jeff Osborne believes risk of cash burn that will hit Tesla in the next years will outweigh “healthy” delivery performance from the company’s older EV models.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts